Status:
UNKNOWN
Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Cancer
Surgery
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
* The surgical method for breast cancer is determined according to the size and location of the remaining lesions after prior chemotherapy. * There are many patients who were able to undergo partial r...
Detailed Description
In a study published by Jennifer F. et al., sensitivity to lesions remaining after prior chemotherapy of breast magnetic resonance imaging was measured as 83%, specificity 47%, PPV 47%, NPV 83%, and a...
Eligibility Criteria
Inclusion
- Breast cancer patients over 20 years of age undergoing surgery at Seoul National University Hospital
- Patients to undergo total mastectomy
- Patients who received neoadjuvant chemotherapy and undergoing total mastectomy were the main subjects, but as a control group, patients who did not receive neoadjuvant chemotherapy but undergoing total mastectomy were included as subjects.
Exclusion
- In case of total mastectomy at the request of the patient
- Except for cases where total resection is performed regardless of size because it is a lesion under the areola and is close to the nipple.
Key Trial Info
Start Date :
March 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04689529
Start Date
March 23 2018
End Date
December 31 2023
Last Update
June 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Jongno-gu, South Korea, 03080